Treatment success rate for patients treated for MDR-TB in China
China: Treatment success rate for patients treated for MDR-TB was 68.0% in 2022. ▲ Rising
Treatment success rate for patients treated for MDR-TB in China, 2008–2022
Source: World Health Organization, Global Health Observatory.
Analysis
China recorded 68.0% for treatment success rate for patients treated for mdr-tb in 2022. That is the highest value across all 15 years on record.
The figure is up 3.0% on the previous year and up 61.9% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in China peaked at 68.0% in 2022 and was at its lowest, 41.0%, in 2014.
That places China 104th out of 163 countries with data for 2022, putting it in the middle of the range.
The long-run direction has been consistently rising across the 15 years of available data.
Treatment success rate for patients treated for MDR-TB in China, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 46.0% | — |
| 2009 | 46.0% | +0.0% |
| 2010 | 42.0% | -8.7% |
| 2011 | 50.0% | +19.0% |
| 2012 | 42.0% | -16.0% |
| 2013 | 55.0% | +31.0% |
| 2014 | 41.0% | -25.5% |
| 2015 | 41.0% | +0.0% |
| 2016 | 52.0% | +26.8% |
| 2017 | 54.0% | +3.8% |
| 2018 | 54.0% | +0.0% |
| 2019 | 53.0% | -1.9% |
| 2020 | 51.0% | -3.8% |
| 2021 | 66.0% | +29.4% |
| 2022 | 68.0% | +3.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 46.0% | 46.0% | 46.0% | 2 |
| 2010s | 48.4% | 41.0% | 55.0% | 10 |
| 2020s | 61.7% | 51.0% | 68.0% | 3 |
Countries ranked near China
More health data for China
- Un projection of annual infant deaths, annual growth rate -1.15 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0985 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,029 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,642 deaths (2100)
- Population ages 40-44, male, annual growth rate 2.37 % change on previous year (2025)
- Population ages 40-44, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, per capita 0.0372 units per person (2025)
- Population ages 45-49, female, annual growth rate -2.14 % change on previous year (2025)
- Population ages 45-49, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 45-49, female, per capita 0.032 units per person (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in China?
- Treatment success rate for patients treated for mdr-tb in China was 68.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in China?
- The highest recorded value was 68.0% in 2022.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in China?
- The lowest recorded value was 41.0% in 2014.
- How does China rank for treatment success rate for patients treated for mdr-tb?
- China ranks 104th out of 163 countries with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in China?
- Over the last ten years it is up 61.9%. The long-run trend across the full record is rising.
- Where does this China data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).